Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00741117 · ClinicalTrials.gov registry record · NA

Conjugated Hyperbilirubinemia and Pulse Oximetry

A NA study, sponsored by Emory University.

Terminated
Registry status
NA
Development phase
4
Enrollment target

NCT00741117: Clinical Trial NA study, sponsored by Emory University.

NCT00741117 is a NA study that was terminated before completion, run by Emory University. The registered enrollment target is 4 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00741117, a NA study, was terminated before completion, sponsored by Emory University.

TERMINATED
Registry status
NA
Development phase
4 participants
Enrollment target

Study Summary

The purpose of this study is to determine if higher levels of bilirubin in the blood of people with liver disease affects how accurate a pulse oximeter machine is able to measure the concentration of oxygen in the blood. Previous studies have reported conflicting results regarding the affect of high levels of bilirubin in the blood on the accuracy of the pulse oximeter reading. Initial studies showed an underestimation of the oxygen concentration in the presence of elevated bilirubin. Subsequent studies have suggested that high levels of bilirubin in the blood do not influence the accuracy of the pulse oximeter machine. However, recent reports in bone marrow transplant literature and our personal observations in patients with liver disease suggest that high bilirubin levels are associated with an overestimation of the oxygen concentration as measured by the pulse oximeter machine.

Interventions

  • PROCEDURE Arterial Blood Gas
  • PROCEDURE Pulse Oximetry Machine
  • PROCEDURE Direct and Indirect Serum Bilirubin Measurement

Trial Details

FieldValue
Enrollment Target 4 participants
Start Date 2011-10
Est. Completion 2011-10
Phase NA
Emory University

1,208 total trials

Why NCT00741117 stopped before completion

NCT00741117 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 4 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).

The record links to 0 conditions, and to 3 interventions - of which Arterial Blood Gas is the first listed.

NCT00741117 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00741117 about?

NCT00741117 is a clinical study titled "Conjugated Hyperbilirubinemia and Pulse Oximetry". The purpose of this study is to determine if higher levels of bilirubin in the blood of people with liver disease affects how accurate a pulse oximeter machine is able to measure the concentration of oxygen in the blood. Previous studies have reported conflicting results regarding the affect of high...

What is the current status of trial NCT00741117?

This trial is currently terminated. It is a NA study. The enrollment target is 4 participants. The study started on 2011-10. Estimated completion is 2011-10.

What interventions are being tested in trial NCT00741117?

The interventions under investigation include: Arterial Blood Gas (PROCEDURE), Pulse Oximetry Machine (PROCEDURE), Direct and Indirect Serum Bilirubin Measurement (PROCEDURE).

Who is sponsoring clinical trial NCT00741117?

This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00741117's enrollment target sits among peer trials

4 1996th of 2000 higher than 5 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00741117, the US trial registry maintained by the National Library of Medicine. NCT00741117 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.